Compare NNOX & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNOX | ORMP |
|---|---|---|
| Founded | 2011 | 2002 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical Electronics | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.6M | 141.3M |
| IPO Year | 2019 | 2010 |
| Metric | NNOX | ORMP |
|---|---|---|
| Price | $2.21 | $3.31 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 593.1K | 123.5K |
| Earning Date | 03-31-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 7.53% |
| EPS Growth | N/A | ★ 412.50 |
| EPS | N/A | ★ 1.50 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | $20.19 | N/A |
| Revenue Next Year | $137.69 | N/A |
| P/E Ratio | ★ N/A | $2.63 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $2.11 | $1.82 |
| 52 Week High | $5.72 | $3.76 |
| Indicator | NNOX | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 32.56 | 44.98 |
| Support Level | $2.11 | $3.21 |
| Resistance Level | $2.75 | $3.72 |
| Average True Range (ATR) | 0.12 | 0.18 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 6.36 | 15.56 |
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.